There were several references to incorporating long read sequencing in research in today's online Oncologist's Journal.
Pasted in one below.
That's the first time i can recall multiple references.
Just what we'd been hoping for!
Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients; Utility of Targeted Deep Sequencing for Biomarker-Selected Clinical Trial
Seung Tae Kim, Kyoung-Mee Kim, Nayoung K.D. Kim, Joon Oh Park, Soomin Ahn, Jae-Won Yun, Kyu-Tae Kim, Se Hoon Park, Peter J. Park, Hee Cheol Kim, Tae Sung Sohn, Dong Il Choi, Jong Ho Cho, Jin Seok Heo, Wooil Kwon, Hyuk Lee, Byung-Hoon Min, Sung No Hong, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Woong-Yang Park, Jeeyun Lee
Advances in sequencing technologies and improved algorithms for detecting specific molecular aberrations make it possible to perform biomarker-driven clinical trials. The analytical sensitivity and clinical validity have not yet been demonstrated in a large cohort. This article describes the implementation of a targeted-sequencing panel in a precision oncology clinic and the feasibility of a clinic-based molecular screening program
Market Data 
Markets 
AI
